Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

Ecolab Rebrands Shield Medicare Division

Feb 13, 2014

Ecolab's Shield Medicare division will now be called Ecolab Contamination Control.

NSF International Acquires Auditing Arm of IPEC-Americas

Feb 11, 2014

NSF-IPEA now can provide excipient auditing and certification.

Mallinckrodt to Acquire Cadence Pharmaceuticals

Feb 11, 2014

Mallinckrodt acquires Cadence Pharmaceuticals for $1.3 million.

GMP Certification Extended for Cobra Biologics

Feb 11, 2014

Cobra Biologics' GMP Compliance Certification has been extended to include QC testing.

Novartis Recognized Among World's Most Sustainable Companies

Feb 7, 2014

Novartis is named among the 2014 Corporate Knights Global 100.

FDA Approves Hetlioz for the Treatment of Non-24-Hour Sleep-Wake Disorder

Feb 7, 2014

Vanda Pharmaceuticals receives approval from FDA for Hetlioz for the treatment of Non-24.

AstraZeneca Completes Acquisition of BMS Global Diabetes Alliance

Feb 7, 2014

AstraZeneca completes the acquisition of the entirety of BSM's interests in the companies' diabetes alliance.

Shimadzu Opens New Solution Center in Maryland

Feb 7, 2014

Shimadzu's new Solution Center features additional research space.

Mylan Launches First Trastuzumab Biosimilar in India

Feb 7, 2014

Mylan Pharmaceuticals launches Hertraz, the world's first trastuzumab biosimilar in India.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here